PRICE TO CASH-FLOW

Price to Cash-Flow of Mylan N.V.




A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Cash-Flow analysis of Mylan N.V.

04-30-2020

 Price USD  16.77
 Cahs-flow per share USD  3.49
 Capitalization (mn) USD  8,604
 Free Cash-flow (mn) USD  1,797
 P/CF ratio 4.80
 Mylan N.V. dividend
 Mylan N.V. Price to book Value
 Mylan N.V. Price to earnings
 Mylan N.V. Return on Equity

Mylan N.V. is a Health Care industry firm, which concentrates their activity in the Pharmaceuticals and Biotechnology sector. Mylan N.V. headquarters are in USA, where the firm is listed.

At the time of this analysis, Mylan N.V. stocks were trading at a price of 16.77 USD after collapsing their price by -37.90% last twelve months.

Based on the following chart, where Price/Cash-flow ratio is shown, Mylan N.V. has P/CF of 4.80, lower than the amount offered by both companies from USA and Pharmaceuticals and Biotechnology subsector. This low Price to cash-flow, might be a sing of a company undervalued or that the market expects a reduction in their cash inflows.Mylan N.V. financial data could confirm which is the explanation for such a low P/CF ratio.

Finally, you could draw a comparisson Mylan N.V. P/CF with other Pharmaceuticals and Biotechnology companies or firms from USA.

Mylan N.V. price to earnings

Next companies

Mytilineos Holdings. Greece. Basic Materials.

Nabtesco Corp. Japan. Industrials.

NagaCorp. Hong-Kong. Consumer Services.

Nagase & Co. Japan. Basic Materials.

Nagoya Railroad. Japan. Consumer Services.

Nan Ya Plastics. Taiwan. Basic Materials.

Previous companies

Muthoot Finance. India. Financials.

Murata Manufacturing. Japan. Industrials.

Multiplan Empreendim. Brazil. Financials.

MultiChoice Group. South Africa. Consumer Services.

Muench. Rueckvers. Germany. Financials.

Muangthai Capital. Thailand. Financials.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.